PET/CT引导肺病灶活检因结果不确定而需二次活检的比例低于CT引导
该前瞻性研究纳入341例患者,216例接受18F-FDG PET/CT引导经皮肺病灶活检、125例接受CT引导活检,比较病理结果、病灶大小、并发症及二次活检率。PET/CT组恶性病灶占78.7%、CT组占61.6%(P=0.001);因结果不确定需二次活检者PET/CT组为2.3%、CT组为10.4%(P=0.001),两组并发症发生率差异无统计学意义(P=0.6)。
要点
- PET/CT引导组因结果不确定需二次活检的比例为2.3%,低于CT引导组的10.4%(P=0.001)。
- 两组并发症发生率差异无统计学意义(P=0.6),未报告危及生命的不良事件或死亡。
- 无论组别,恶性病灶平均大小均大于良性病灶(P=0.015)。
核心结论
- PET/CT引导肺病灶活检因结果不确定而需二次活检的比例低于CT引导,且并发症发生率相似。
研究设计与样本
- 前瞻性研究纳入341例患者,其中216例接受18F-FDG PET/CT引导经皮活检、125例接受CT引导活检,评估病理结果、病灶大小、并发症及二次活检率。
主要发现
- PET/CT引导组216例中恶性170例(78.7%)、良性46例(21.3%);CT引导组125例中恶性77例(61.6%)、良性48例(38.4%)(P=0.001)。
- 因结果不确定需二次活检者共18例,CT组13/125(10.4%)、PET/CT组5/216(2.3%)(P=0.001)。
- 并发症包括气胸(13.2%)、血胸(0.8%)和咯血(0.6%),两组并发症发生率差异无统计学意义(P=0.6)。
- 无论组别,恶性病灶平均大小均大于良性病灶(P=0.015)。
临床怎么用
- 对疑似肺病灶行经皮活检时,可优先考虑18F-FDG PET/CT引导以降低因结果不确定而需二次活检的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this study was to compare 18F-FDG PET/CT and CT performance in guiding percutaneous biopsies with histologic confirmation of lung lesions. Methods: We prospectively evaluated 341 patients, of whom 216 underwent 18F-FDG PET/CT-guided biopsy and 125 underwent CT-guided biopsy. The pathology results, lesion size, complications, and rebiopsy rate in the 2 groups were evaluated. Results: Of the 216 biopsies with PET/CT guidance, histology demonstrated 170 lesions (78.7%) to be malignant and 46 (21.3%) to be benign. In the CT-guided group, of 125 lesions, 77 (61.6%) were malignant and 48 (38.4%) were benign (P = 0.001). Inconclusive results prompted the need for a second biopsy in 18 patients: 13 of 125 (10.4%) in the CT group and 5 of 216 (2.3%) in PET group (P = 0.001). Complications were pneumothorax (13.2%), hemothorax (0.8%), and hemoptysis (0.6%). No life-threatening adverse events or fatalities were reported. The difference in complication rates between the 2 groups was not significant (P = 0.6). Malignant lesions showed a greater mean size than benign lesions regardless of the group (P = 0.015). Conclusion: PET/CT-guided biopsy of lung lesions led to fewer inconclusive biopsies than CT-guided biopsy, with similar complication rates.
引用
- Cerci JJ, Bogoni M, Cerci RJ, et al. PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results. J Nucl Med. 2020. PMID: 33384323. doi:10.2967/jnumed.120.252403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。